Laboratorios Richmond SACIF Total Liabilities

Latest as of September 2025: AR$282.24 Billion ARS ≈ $204.23 Million USD

Laboratorios Richmond SACIF total liabilities. Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) has total liabilities worth AR$282.24 Billion ARS (≈ $204.23 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Laboratorios Richmond SACIF liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Laboratorios Richmond SACIF (2006–2024)

Total liabilities of Laboratorios Richmond SACIF from 2006 to 2024. This chart illustrates how Laboratorios Richmond SACIF's total liabilities have evolved over time, based on quarterly financial data. Explore Laboratorios Richmond SACIF strategic investment ratio to see how much of total assets are deployed in long-term investments.

Laboratorios Richmond SACIF Competitors by Total Liabilities

The table below lists competitors of Laboratorios Richmond SACIF ranked by their total liabilities.

Company Country Total Liabilities
TEKNA HOLDING ASA NK 2
F:8VB
Germany €18.33 Million
DCC plc
LSE:DCC
UK GBX5.52 Billion
Deneb Investments Ltd
JSE:DNB
South Africa ZAC1.34 Billion
Hai Kwang Enterprise Corp
TW:2038
Taiwan NT$5.04 Billion
Internet Thailand Public Company Limited
BK:INET
Thailand ฿13.99 Billion
LENSAR Inc
NASDAQ:LNSR
USA $54.65 Million
Lion Finance Group PLC
LSE:BGEO
UK GBX56.43 Billion
Tycoons Group Enterprise Co Ltd
TW:2022
Taiwan NT$4.50 Billion

Liability Composition Analysis (2006–2024)

This chart breaks down Laboratorios Richmond SACIF's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Laboratorios Richmond SACIF balance sheet assets.

Liquidity & Leverage Metrics

Laboratorios Richmond SACIF Total Liabilities Ratios Explained

Laboratorios Richmond SACIF total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.05 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.96 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.80 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Laboratorios Richmond SACIF's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Laboratorios Richmond SACIF (2006–2024)

The table below shows the annual total liabilities of Laboratorios Richmond SACIF from 2006 to 2024.

Year Total Liabilities Change
2024-12-31 AR$194.80 Billion
≈ $140.96 Million
-32.20%
2023-12-31 AR$287.34 Billion
≈ $207.92 Million
+842.02%
2022-12-31 AR$30.50 Billion
≈ $22.07 Million
+50.13%
2021-12-31 AR$20.32 Billion
≈ $14.70 Million
+327.48%
2020-12-31 AR$4.75 Billion
≈ $3.44 Million
+56.62%
2019-12-31 AR$3.03 Billion
≈ $2.20 Million
+90.35%
2018-12-31 AR$1.59 Billion
≈ $1.15 Million
+84.39%
2017-12-31 AR$864.59 Million
≈ $625.62K
+28.72%
2016-12-31 AR$671.67 Million
≈ $486.03K
+53.80%
2015-12-31 AR$436.71 Million
≈ $316.01K
+49.23%
2014-12-31 AR$292.64 Million
≈ $211.76K
+49.05%
2013-12-31 AR$196.34 Million
≈ $142.07K
+9.72%
2012-12-31 AR$178.94 Million
≈ $129.48K
+64.29%
2011-12-31 AR$108.92 Million
≈ $78.82K
+19.74%
2010-12-31 AR$90.96 Million
≈ $65.82K
+22.74%
2009-12-31 AR$74.11 Million
≈ $53.62K
+3.88%
2008-12-31 AR$71.34 Million
≈ $51.62K
+10.89%
2007-12-31 AR$64.33 Million
≈ $46.55K
+32.35%
2006-12-31 AR$48.61 Million
≈ $35.17K
--

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic
Market Cap
$66.97 Million
AR$92.55 Billion ARS
Market Cap Rank
#20523 Global
#56 in Argentina
Share Price
AR$1390.00
Change (1 day)
+6.92%
52-Week Range
AR$1290.00 - AR$2165.00
All Time High
AR$2165.00
About

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs … Read more